Comparison Between XELOX and S1, Oxaliplatin and Docetaxel as Neoadjuvant Chemotherapy for Gastric Cancer

NCT02623153 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Oxaliplatin
DRUG: capecitabine
DRUG: S1
DRUG: Docetaxel

Sponsor

Tianshu Liu